All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The natural antigens of group 2 CD1 are not well-characterized, but a synthetic glycolipid, alpha-galactosylceramide, originally isolated from a compound found in a marine sponge, has strong biologic activity.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-C028Z | Human anti-CD1d-α-GalCer T cell receptor (INKT), pCDTCR1 | INKT | Human | Lentiviral | ||||
TCR-C029Z | Human anti-CD1d-α-GalCer T cell receptor (5E), pCDTCR1 | 5E | Human | Lentiviral | ||||
TCR-C030Z | Human anti-CD1d-α-GalCer T cell receptor (5B), pCDTCR1 | 5B | Human | Lentiviral | ||||
TCR-C031Z | Human anti-CD1d-α-GalCer T cell receptor (NKT15), pCDTCR1 | NKT15 | Human | Lentiviral | ||||
TCR-C032Z | Human anti-CD1d-α-GalCer T cell receptor (9C2), pCDTCR1 | 9C2 | Human | Lentiviral | ||||
TCR-C033Z | Human anti-CD1d–α-GalCer T cell receptor (9B4), pCDTCR1 | 9B4 | Human | Lentiviral |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION